Get set for…
Revamped Panel Discussions
Including over Two Dozen Faculty Members from Industry and The Judiciary
Days of Networking
We are Thrilled to Announce Our 2021 Conference Co-Chairs:
Senior Vice President, Head of Global Litigation
Assistant General Counsel, Litigation
Meet, Network With and Gain Essential Insights from Leading In-House Counsel, Including:
Assistant General Counsel
Johnson & Johnson
Christopher M. Guth
Senior Assistant General Counsel
Assistant General Counsel – Litigation and Government Investigations
Adrienne M. Hollander
Assistant General Counsel
American Regent Inc., a Daiichi Sankyo Group Company
Senior Legal Counsel, Litigation
Senior Litigation Counsel
Nuvasive (San Diego, CA)
Michele Suggs Adeleye
Vice President and AGC
Pfizer (New York, NY)
Hear from our Esteemed Judges:
Honorable Karen K. Caldwell
Chief Judge – U.S. District Court, E.D. Kentucky
Chair – Judicial Panel on Multidistrict Litigation (JPML)
Honorable Nancy J. Rosenstengel
Chief District Judge
U.S. District Court, S.D. Illinois (East St. Louis, IL)
Honorable William F. Highberger
Superior Court Judge
Los Angeles County Superior Court
Honorable Eduardo C. Robreno
U.S. District Court, E.D. Pennsylvania
Honorable John R. Tunheim
U.S. District Court, D. Minnesota
Don’t miss this year’s conference highlights
Hybrid Virtual/In-Person Trial Practice Toolkit
Leading trial attorneys will explore post-pandemic trial practice, new and evolving client and court expectations, and strategies for conducting litigation in a hybrid virtual/in-person world.
FDA Think Tank
Former FDA Chief Counsels will examine the latest FDA initiatives influencing the products liability sphere.
New MDL Focus Sessions
Leading defense counsel will engage in in-depth discussions on combatting plaintiff tactics that transform MDLs into the behemoth litigations we see today as well as navigating the remand process from transfer to trial.
FDA Think Tank Spotlight on Opioid and NDMA Litigations
Two all-star panels will explore takeaways from the NDMA and opioid litigations and explain how this is significant for future product liability trial practice in the life sciences.
Post-COVID-19 Jury Data Unveiled
Leading jury consultants will share data on how the COVID-19 pandemic is actually impacting juror mindsets, perceptions, and verdicts.
Roadmap for Post-Albrecht Preemption
Top drug and device product liability litigators will analyze and discuss recent rulings to create a future roadmap for obtaining Albrecht preemption.
WHAT SETS US APART?
Your once-a-year opportunity to brainstorm with top in-house counsel including General Counsel and Chief Litigation Officers from diverse pharmaceutical and medical device companies and members of the products liability defense bar
Strengthen Relationships & Establish New Connections
Network and brainstorm with the Who’s Who of the products liability defense bar from leading litigators in the field as well as from over 25 in-house counsel responsible for handling litigation on behalf of the country’s top life sciences companies
The Most Relevant,
Join in high-level sessions focused on your most pressing challenges and opportunities
Federal and State Judges and
Gain a 360 degree view of products liability litigation from all the key stakeholders
See why professionals attend each year to network and discuss actionable strategies to surmount new litigation challenges.
WHO SHOULD ATTEND
In-house counsel for:
Medical Device Companies
Health Care Organizations
Attorneys practicing in:
Drug and Medical Devices
Complex and Multidistrict Litigation Healthcare
ACI’s Global Series of Life Sciences Conferences Bring together key sector stakeholders from around the globe to explore the most important trends impacting the many industries including pharmaceutical, biotechnology, medical device/diagnostic, and FDA-regulated consumer products. Our events cover every facet of legal and business relevance as well as controversy. Learn More